Maxcyte (MXCT) Return on Capital Employed (2021 - 2026)

Maxcyte (MXCT) reported Return on Capital Employed of 1.73% for Q1 2026, up 214.0% year-over-year from 0.55% in Q1 2025, and up 64.19% on a QoQ basis from 4.84% in Q4 2025.

Maxcyte (MXCT) has 6 years of Return on Capital Employed data on file, last reported at 1.73% in Q1 2026.

  • Quarterly Return on Capital Employed rose 214.0% year-over-year to 1.73% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.73% (up 214.0% YoY) and the FY2025 annual result came in at 4.53%, down 93.0% from the prior year.
  • Return on Capital Employed climbed to 1.73% in Q1 2026 per MXCT's latest filing, from 4.84% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 1.73% in Q1 2026 and bottomed at 19.96% in Q3 2024.
  • The 5-year median for Return on Capital Employed is 9.42% (2022), against an average of 10.75%.
  • The widest annual swing landed in 2023, when Return on Capital Employed sank 925 bps; it then soared 1559 bps in 2024.
  • Tracing MXCT's Return on Capital Employed over 5 years: stood at 10.09% in 2022, then sank by 92 bps to 19.35% in 2023, then soared by 81 bps to 3.76% in 2024, then declined by 29 bps to 4.84% in 2025, then soared by 64 bps to 1.73% in 2026.
  • Per Business Quant, the three latest MXCT Return on Capital Employed figures stand at 1.73% (Q1 2026), 4.84% (Q4 2025), and 5.47% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.61%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 12.24%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 7.36%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 9.62%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 11.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 7.62%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 24.24%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.30%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 11.57%
10 Maxcyte 129.85 Mn 129.85 Mn 8.08 Mn -1.73%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.73%
Dec 31, 2025 -4.84%
Sep 30, 2025 -5.47%
Jun 30, 2025 -5.09%
Mar 31, 2025 -3.88%
Dec 31, 2024 -3.76%
Sep 30, 2024 -19.96%
Jun 30, 2024 -19.09%
Mar 31, 2024 -18.99%
Dec 31, 2023 -19.35%
Sep 30, 2023 -18.61%
Jun 30, 2023 -15.47%
Mar 31, 2023 -13.60%
Dec 31, 2022 -10.09%
Sep 30, 2022 -9.42%
Jun 30, 2022 -7.45%
Mar 31, 2022 -5.87%
Dec 31, 2021 -6.86%
Sep 30, 2021 -4.07%